News
-
-
PRESS RELEASE
PALFINGER AG – strong results in 1st HY 2024, further capacity adjustments necessary in EMEA
PALFINGER AG reports strong results in 1st half-year 2024 with revenue of EUR 1,175.4 million and EBIT of EUR 112.2 million. Further capacity adjustments necessary in EMEA due to market challenges -
-
-
-
PRESS RELEASE
Continued strong customer growth and solid financial results in Q2 – guidance for 2024 confirmed
Sunrise UPC GmbH reports strong customer growth and solid financial results in Q2 2024, exceeding revenue and EBITDA expectations. Confirmation of 2024 guidance reflects consistent performance -
PRESS RELEASE
Substantial pipeline progress at several portfolio companies offsets rate-related market volatility
BB Biotech AG reports substantial pipeline progress at several portfolio companies, offsetting market volatility. Performance review, leadership change, and outlook provided. Full report available at bbbiotech.com -
-
-